Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
ConditionSickle Cell Trait
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational Alliance for Sickle Cell Centers
About this trial
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.
Eligibility criteria
Qualifiers
Are willing to voluntarily participate and sign the study consent
Know/suspect they have SCT and are willing to get tested to confirm/learn about their SCT status
Adults ages 18 and older
Disqualifiers
Unwilling to sign consent
Known end-stage renal disease or dialysis
Known SCD (including sickle cell-beta thalassemia)
People who do not have SCT
Trial design
Treatments tested in this trial
- Biologic Specimen Collection
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
National Alliance for Sickle Cell Centers
Lead sponsor
Beam Therapeutics Inc.
Collaborator
Source ClinicalTrials.gov